Body Image Scale, Rosenberg’s Self-Esteem Scale, Beck Depression Inventory, and Beck Anxiety Inventory were used.

ResultsAge had a significant main effect on psychological distress but the type of cancer did not. Younger women showed significantly greater distress than older women (p-values<0.001). A significant interaction between age and type of cancer was found, indicating that older learn more women with breast cancer had worse body image and more depression than those with gynecological cancer (p-values<0.001); no significant differences were found between

younger groups. The prediction model for increased body image disturbance and depression included the joint effect of the following variables: being younger, inactive occupational status, and post-adjuvant therapy side effects. For lower self-esteem, the variables were: being younger, post-adjuvant therapy side

effects, and dissatisfaction with social support. And for higher anxiety, the sole variable included see more was post-adjuvant therapy side effects.

ConclusionsBoth mastectomy and hysterectomy/oophorectomy cause similar psychological distress in younger women, but mastectomy causes greater distress in older women than hysterectomy/oophorectomy. Copyright (c) 2013 John Wiley & Sons, Ltd.”
“In a recent article Narasimha [J. Appl. Phys. 105, 073506 (2009)] claim to show that the shape of static displacement pulses generated by ultrasonic tone-bursts in nondispersive solids is that of a growing trapezoid in the spatial domain that leads to a flat-topped pulse shape in the time domain for a fixed spatial position. Flaws in their theoretical arguments are corrected to show that their model actually predicts a right-triangular pulse shape for nondispersive monocrystals in both the spatial and time domains as originally reported by Yost and Cantrell [Phys. Rev. B 30, 3221 (1984)] and Cantrell [Phys. Rev. B 35, 9780 (1987)]. [doi: 10.1063/1.3457850]“
“Aim:

Etoposide is used in a wide variety of solid and hematological tumors. It is available

in Australia check details in two intravenous formulations; etoposide base and the etoposide phosphate salt with 113.6 mg of etoposide phosphate being equivalent to 100 mg of the etoposide base. Variances between the etoposide dose prescribed and that actually given have been reported recently in Australia with patients receiving either too much or too little of the intended dose of etoposide. We carried out a review of national practices of prescribing, dispensing and labeling of etoposide and etoposide phosphate.

Methods:

Cancer care clinicians and pharmacists, identified through their membership of the Clinical Oncological Society of Australia (COSA), were asked to complete an online survey or participate in a telephone interview, about their etoposide prescribing and dispensing practices.

Results:

Nineteen pharmacists and 11 prescribers provided responses suitable for analysis.